HK1209351A1 - Use of haemophilus parainfluenzae in the treatment or prevention of rheumatoid arthritis or related diseases - Google Patents

Use of haemophilus parainfluenzae in the treatment or prevention of rheumatoid arthritis or related diseases

Info

Publication number
HK1209351A1
HK1209351A1 HK15110146.5A HK15110146A HK1209351A1 HK 1209351 A1 HK1209351 A1 HK 1209351A1 HK 15110146 A HK15110146 A HK 15110146A HK 1209351 A1 HK1209351 A1 HK 1209351A1
Authority
HK
Hong Kong
Prior art keywords
prevention
treatment
rheumatoid arthritis
related diseases
haemophilus parainfluenzae
Prior art date
Application number
HK15110146.5A
Other languages
Chinese (zh)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of HK1209351A1 publication Critical patent/HK1209351A1/en

Links

HK15110146.5A 2014-09-30 2015-10-15 Use of haemophilus parainfluenzae in the treatment or prevention of rheumatoid arthritis or related diseases HK1209351A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410522308.2A CN104546930B (en) 2014-09-30 2014-09-30 Haemophilus parainfluenzae is treating or preventing the application in rheumatoid arthritis or its related disease

Publications (1)

Publication Number Publication Date
HK1209351A1 true HK1209351A1 (en) 2016-04-01

Family

ID=53064702

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15110146.5A HK1209351A1 (en) 2014-09-30 2015-10-15 Use of haemophilus parainfluenzae in the treatment or prevention of rheumatoid arthritis or related diseases

Country Status (2)

Country Link
CN (1) CN104546930B (en)
HK (1) HK1209351A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106974262B (en) * 2016-01-15 2021-05-25 深圳华大生命科学研究院 Application of intestinal probiotic bacillus in treating and preventing obesity and related diseases
CN107832584B (en) * 2017-09-18 2021-06-22 中国科学院深圳先进技术研究院 Gene analysis method, device, equipment and storage medium of metagenome
EP3786305A4 (en) * 2018-04-24 2022-07-13 BGI Shenzhen Biomarker for depression and use thereof
CN110751985B (en) * 2019-09-20 2022-08-19 上海交通大学 Gut microbial markers highly correlated with large heavy chickens
CN110656153B (en) * 2019-09-20 2021-08-20 上海交通大学 Intestinal microbial markers highly correlated with anorexia behavior in small-weight chickens

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9104838D0 (en) * 1991-03-07 1991-04-17 Glaxo Spa Heterocyclic compounds
US5248605A (en) * 1992-12-07 1993-09-28 Life Technologies, Inc. Cloning and expressing restriction endonucleases from haemophilus
MXPA06003573A (en) * 2003-09-30 2006-08-31 Kohi Corp Compositions and methods for treating burns.
EP1957449A1 (en) * 2005-12-01 2008-08-20 Schering Corporation Compounds for the treatment of inflammatory disorders and microbial diseases

Also Published As

Publication number Publication date
CN104546930A (en) 2015-04-29
CN104546930B (en) 2019-04-12

Similar Documents

Publication Publication Date Title
IL283086A (en) Use of cannabidiol in the treatment of tuberous sclerosis complex
HK1209360A1 (en) Use of bacteroides ovatus in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209347A1 (en) Use of bacteroides dorei in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209365A1 (en) Use of bacteroides plebeius in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209350A1 (en) Use of bacteroides caccae in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209349A1 (en) Use of parabacteroides merdae in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209348A1 (en) Use of bacteroides thetaiotaomicron in the treatment or prevention of rheumatoid arthritis or related diseases
PL3157512T3 (en) Use of cannabidiol in the treatment of epilepsy
GB201411496D0 (en) Use of 7-Oh-Cannabidiol (7-Oh-CBD) and/or 7-Oh-Cannabidvarin (7-Oh-CBDV) in the treatment of epilepsy
HK1245658A1 (en) Nutritional composition useful in the treatment of ibd patients
PL3277280T3 (en) Isomyosmine for use in the treatment of autoimmune diseases
IL251904B (en) Apilimod for use in the treatment of melanoma
HK1209346A1 (en) Use of bifidobacterium bifidum in the treatment or prevention of rheumatoid arthritis or related diseases
GB201417163D0 (en) Substituted pyrimidine derivatives useful in the treatment of autoimmune diseases
HK1209351A1 (en) Use of haemophilus parainfluenzae in the treatment or prevention of rheumatoid arthritis or related diseases
HUE039750T2 (en) 6-hydroxybuspirone for use in the treatment of movement disorders
PT3177599T (en) Fumarate analogs and uses thereof in the treatment of an autoimmune disease or an inflammatory disease
HK1209359A1 (en) Use of megamonas hypermegale in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209366A1 (en) Use of lactococcus lactis in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209363A1 (en) Use of lactobacillus crispatus in the treatment or prevention of rheumatoid arthritis or related diseases
IL247882B (en) A composition for use in the treatment of intervertebral disc-related pain
HK1209357A1 (en) Use of dialister invisus in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209369A1 (en) Use of alistipes shahii in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209367A1 (en) Use of clostridium nexile in the treatment or prevention of rheumatoid arthritis or related diseases
HK1209368A1 (en) Use of prevotella maculosa in the treatment or prevention of rheumatoid arthritis or related diseases